摘要
背景:慢病毒载体是一个能够在原代培养的人树突状细胞中进行RNA干扰的有效工具,但目前国内对RNA干扰技术应用于人树突状细胞特异性细胞间黏附分子-3-结合非整合素分子的研究却少有报道。目的:拟构建人树突状细胞特异性细胞间黏附分子-3-结合非整合素基因RNA干扰慢病毒载体,为调控人树突状细胞特异性细胞间黏附分子-3-结合非整合素表达水平提供有利的工具。方法:根据人树突状细胞特异性细胞间黏附分子-3-结合非整合素基因的mRNA序列选择4条靶序列,设计合成靶序列的Oligo DNA,退火形成双链DNA,与经AgeⅠ和EcoRⅠ双酶切后的pGCSIL-GFP载体连接产生DC-SIGN慢病毒载体,采用PCR及测序鉴定,应用Westernblot技术外源性筛选干扰效率高的有效靶序列。用慢病毒包装系统pGCSIL-GFP、pHelper1.0和pHelper2.0共转染包装293T细胞,包装产生慢病毒,以系列稀释法测定病毒滴度。结果与结论:PCR扩增和测序结果显示,人树突状细胞特异性细胞间黏附分子-3-结合非整合素核苷酸链序列插入正确,外源性筛选确定两条干扰效率高的有效靶序列。利用筛选确定的有效靶序列,包装产生慢病毒,其浓缩病毒悬液的滴度为1×109TU/mL。证实实验成功构建了DC-SIGN基因慢病毒载体。
BACKGROUND: The lentiviral vector is an effective tool to execute RNAi in the human dendritic cells. However, there are few reports addressing applying RNAi technology to the human dendritic cell-specific intercellular adhesion molecule 3 grabbing nonintergrin (DC-SIGN). OBJECTIVE: To construct a lentiviral vector expressing small-hairpin RNA (shRNA) targeting human DC-SIGN gene, and to provide a useful tool to regulate the expression level of DC-SIGN. METHODS: Four target sequences were selected according to human DC-SIGN mRNA sequence.The cDNA target sequence containing both sense and antisense Oligo DNA were designed. The obtained lentiviral vector containing DC-SIGN shRNA was confirmed by PCR, sequencing and exogenous selection. 293T cells were cotransfected with lentiviral vector pGCSIL-GFP, pHelper1.0 and pHelper 2.0. The titer of virus was tested by serial dilution. RESULTS AND CONCLUSION: PCR and DNA sequencing demonstrated that the inserted sequences were correct. Two effective targeting sequences were determined by exogenous selection. The titer of concentrated virus was 1×109T U/mL. The lentivirus vector targeting DC-SIGN has been successfully constructed.
出处
《中国组织工程研究与临床康复》
CAS
CSCD
北大核心
2010年第41期7691-7695,共5页
Journal of Clinical Rehabilitative Tissue Engineering Research
基金
国家自然科学基金资助项目(30571653)
重庆市卫生局科研项目(05-2-113)
课题名称:DC-SIGN分子删除对结核病发生与转归影响研究~~